Ori Hadomi

Zebra Medical Vision Ltd. engages in the development of medical imaging insights platform. The firm's solution enables researchers to develop imaging algorithms and insights based on large scale datasets and advanced processing power. The company was founded by Eyal Toledano, Eyal Gura, and Elad Benjamin in 2014 and is headquartered in Shfayim, Israel.

Precise Bio, Inc. is a regenerative medicine company that specializes in bio-printed tissues and organs for patients in ophthalmology. The company is based in Winston-Salem, NC. The company's main focus is on developing a bio-printed cornea graft to replace donor corneas. The company is also working on a 3D cardiac tissue "patch" for post myocardial infarction implant to retrieve cardiac muscle viability and functionality. Precise Bio uses an integrated 3D printing and tissue-engineering platform to produce scalable, repeatable bio-fabricated organs from the patients' own cells. The company was founded in 2015 by Anthony Atala, Aryeh Batt, Shay Soker. Aryeh Batt has been the CEO since 2015.

Zebra Medical Vision Ltd. engages in the development of medical imaging insights platform. The firm's solution enables researchers to develop imaging algorithms and insights based on large scale datasets and advanced processing power. The company was founded by Eyal Toledano, Eyal Gura, and Elad Benjamin in 2014 and is headquartered in Shfayim, Israel.

Zebra Medical Vision Ltd. engages in the development of medical imaging insights platform. The firm's solution enables researchers to develop imaging algorithms and insights based on large scale datasets and advanced processing power. The company was founded by Eyal Toledano, Eyal Gura, and Elad Benjamin in 2014 and is headquartered in Shfayim, Israel.

Zebra Medical Vision Ltd. engages in the development of medical imaging insights platform. The firm's solution enables researchers to develop imaging algorithms and insights based on large scale datasets and advanced processing power. The company was founded by Eyal Toledano, Eyal Gura, and Elad Benjamin in 2014 and is headquartered in Shfayim, Israel.

Precise Bio, Inc. is a regenerative medicine company that specializes in bio-printed tissues and organs for patients in ophthalmology. The company is based in Winston-Salem, NC. The company's main focus is on developing a bio-printed cornea graft to replace donor corneas. The company is also working on a 3D cardiac tissue "patch" for post myocardial infarction implant to retrieve cardiac muscle viability and functionality. Precise Bio uses an integrated 3D printing and tissue-engineering platform to produce scalable, repeatable bio-fabricated organs from the patients' own cells. The company was founded in 2015 by Anthony Atala, Aryeh Batt, Shay Soker. Aryeh Batt has been the CEO since 2015.

Precise Bio, Inc. is a regenerative medicine company that specializes in bio-printed tissues and organs for patients in ophthalmology. The company is based in Winston-Salem, NC. The company's main focus is on developing a bio-printed cornea graft to replace donor corneas. The company is also working on a 3D cardiac tissue "patch" for post myocardial infarction implant to retrieve cardiac muscle viability and functionality. Precise Bio uses an integrated 3D printing and tissue-engineering platform to produce scalable, repeatable bio-fabricated organs from the patients' own cells. The company was founded in 2015 by Anthony Atala, Aryeh Batt, Shay Soker. Aryeh Batt has been the CEO since 2015.

Precise Bio, Inc. is a regenerative medicine company that specializes in bio-printed tissues and organs for patients in ophthalmology. The company is based in Winston-Salem, NC. The company's main focus is on developing a bio-printed cornea graft to replace donor corneas. The company is also working on a 3D cardiac tissue "patch" for post myocardial infarction implant to retrieve cardiac muscle viability and functionality. Precise Bio uses an integrated 3D printing and tissue-engineering platform to produce scalable, repeatable bio-fabricated organs from the patients' own cells. The company was founded in 2015 by Anthony Atala, Aryeh Batt, Shay Soker. Aryeh Batt has been the CEO since 2015.